Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$53.43 - $68.12 $3.25 Million - $4.14 Million
-60,800 Reduced 25.25%
180,000 $11.1 Million
Q4 2022

Feb 14, 2023

BUY
$61.23 - $83.62 $1.69 Million - $2.31 Million
27,600 Added 12.95%
240,800 $15.3 Million
Q3 2022

Nov 14, 2022

BUY
$65.58 - $84.69 $209,856 - $271,008
3,200 Added 1.52%
213,200 $15.5 Million
Q2 2022

Aug 15, 2022

BUY
$52.13 - $93.81 $4.53 Million - $8.15 Million
86,878 Added 70.56%
210,000 $14.3 Million
Q1 2022

May 16, 2022

BUY
$64.92 - $99.47 $3.31 Million - $5.06 Million
50,910 Added 70.5%
123,122 $11.2 Million
Q4 2020

Feb 16, 2021

SELL
$60.0 - $87.29 $197,280 - $287,009
-3,288 Reduced 4.35%
72,212 $6.3 Million
Q2 2020

Aug 14, 2020

BUY
$42.51 - $52.46 $3.21 Million - $3.96 Million
75,500 New
75,500 $3.66 Million

Others Institutions Holding NARI

About Inari Medical, Inc.


  • Ticker NARI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 53,389,700
  • Market Cap $2.96B
  • Description
  • Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels, as well as for treatment of ...
More about NARI
Track This Portfolio

Track Novo Holdings Portfolio

Follow Novo Holdings and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Novo Holdings, based on Form 13F filings with the SEC.

News

Stay updated on Novo Holdings with notifications on news.